Cannabis-Based Medicines: Little Evidence for Mental Health Efficacy

Cannabis-based medicines have shown minimal efficacy in treating most mental health and substance-use disorders, as per a recent study published in a major medical journal. The research reviewed 54 randomized clinical trials conducted since 1980, involving 2,477 participants, and highlights the need for more comprehensive trials for definitive conclusions.

Despite an increase in the medical use of cannabinoids for anxiety, PTSD, and sleep disorders, the review found insufficient evidence supporting their effectiveness for these conditions. Notably, significant gaps remain, particularly in studying cannabinoids' effects on depression, which requires urgent research attention, according to lead author Jack Wilson.

Some benefits were noted in reducing tic severity in Tourette's syndrome and addressing cannabis-use disorder's withdrawal symptoms, but the quality of evidence for conditions like autism and insomnia remains low. Researchers stress the importance of higher-quality trials to evaluate the potential therapeutic role of cannabinoids amid their expanding clinical use.